Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

1.24
+0.06005.08%
Post-market: 1.21-0.0300-2.42%19:01 EDT
Volume:983.01K
Turnover:1.19M
Market Cap:254.20M
PE:-3.47
High:1.26
Open:1.19
Low:1.13
Close:1.18
Loading ...

Taysha Gene Therapies price target raised to $8 from $6 at Canaccord

TIPRANKS
·
15 Nov 2024

Q3 2024 Taysha Gene Therapies Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Nov 2024

Taysha Gene Therapies Price Target Maintained With a $7.00/Share by Cantor Fitzgerald

Dow Jones
·
14 Nov 2024

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

GuruFocus.com
·
14 Nov 2024

Taysha Gene Therapies: Promising Developments and Strong Financial Position Support Buy Rating

TIPRANKS
·
14 Nov 2024

Taysha Gene Therapies Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
14 Nov 2024

Taysha Gene Therapies Q3 2024 GAAP EPS $(0.10) Misses $(0.09) Estimate, Sales $1.788M Beat $1.648M Estimate

Benzinga
·
14 Nov 2024

Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings

Benzinga
·
13 Nov 2024

Taysha Gene Therapies Up Nearly 39%, on Pace for Largest Percent Increase Since August 2023 -- Data Talk

Dow Jones
·
13 Nov 2024

Cantor Fitzgerald Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)

TIPRANKS
·
12 Nov 2024

Buy Rating Affirmed for Taysha Gene Therapies Amid Promising TSHA-102 Trial Results

TIPRANKS
·
12 Nov 2024

Piper Sandler Releases a Buy Rating on Taysha Gene Therapies (TSHA)

TIPRANKS
·
12 Nov 2024

Taysha Gene Therapies Price Target Maintained With a $6.00/Share by Needham

Dow Jones
·
12 Nov 2024

Taysha Gene Therapies Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Promising Developments in Taysha Gene Therapies’ MECP2 Treatment Boost Analyst’s Positive Outlook

TIPRANKS
·
12 Nov 2024

US Penny Stocks To Watch In November 2024

Simply Wall St.
·
12 Nov 2024

Neurogene plummets 35% on gene therapy trial data for Rett syndrome

seekingalpha
·
12 Nov 2024

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

GlobeNewswire
·
06 Nov 2024

Optimistic Buy Rating for Taysha Gene Therapies Amid Promising Rett Syndrome Study Outcomes

TIPRANKS
·
05 Nov 2024